It is truly rewarding to be able to reflect over the past 25 years, cherishing the relationships we have built, and proud of the growth and success we have experienced.
Durham, NC (PRWEB) September 18, 2013
Cato Research (CATO) celebrates 25 years of dedicated service to the life science industry. CATO has navigated decades of successful health care research and development, bringing products to the market that ultimately may help those who need them the most.
Headquartered in the Research Triangle Park of North Carolina, CATO is a global, competitive contract research organization that includes an investment arm, Cato BioVentures. Together, CATO and Cato BioVentures have helped biotech companies, pharmaceutical companies, and investors develop their products and bring them to market. CATO has a proven track record of effective collaboration, saving time and reducing cost without jeopardizing product quality while meeting the clinical and regulatory project challenges. The combination of these attributes and capabilities makes for many successful years of business.
“It is truly rewarding to be able to reflect over the past 25 years, cherishing the relationships we have built, and proud of the growth and success we have experienced. Most important to us are the patients we have been able to help by bringing products to the market that have made a difference to their lives. We are thankful and look forward to servicing this industry many more years to come,” says Lynda Sutton, President and cofounder of Cato Research and Cato BioVentures.
Cofounded in 1988 by Allen Cato, M.D., Ph.D., and Lynda Sutton, CATO will celebrate its 25th year by holding several wine tastings throughout the United States at its many office locations. These events will include evenings filled with highly rated wines and delightful hors d'oeuvres, accompanied with lots of mingling. The celebration begins in Boston, Massachusetts, and will conclude in Durham, North Carolina. More information is detailed below.
Celebrate with CATO at the following locations and dates:
Cato Research Boston office
Boston, MA USA
Wednesday, 18 September 2013
Cato Research Washington, D.C. office
Washington, D.C. USA
Tuesday, 08 October 2013
Cato Research San Diego office
San Diego, CA USA
Tuesday, 15 October 2013
FINALE: Cato Research Durham office
Durham, NC USA
Tuesday, 29 October 2013
More information and registration links can be found at:
About Cato BioVentures
Cato BioVentures is the venture capital affiliate of Cato Research, a global contract research and development organization (CRO). For over 20 years, Cato BioVentures and Cato Research have partnered with entrepreneurs, academic institutions, and a broad base of biotechnology and pharmaceutical companies to advance a robust portfolio of successful product development programs. Through strategic CRO service agreements with Cato Research, Cato BioVentures has invested its CRO Service Capital™ in innovative therapeutics, medical devices, and stem cell technologies that improve the pharmaceutical industry’s research and development productivity. If strategic outsourcing for development, regulatory, and clinical support is a core component of a company’s business plan, then Cato BioVenture’s investment model can make a positive difference in that company’s overall success.
About Cato Research
Founded in 1988 by Dr. Allen Cato and Lynda Sutton and headquartered near Research Triangle Park, North Carolina, Cato Research is a full-service contract research and development organization providing strategic and tactical support for clients in the pharmaceutical, biotechnology, and medical device industries. Services range from design and management of preclinical and clinical studies to submission of regulatory documents required for marketing approval. With a staff of approximately 300 and offices located in the United States, Europe, Canada, Israel, and South Africa, Cato Research consistently demonstrates an unsurpassed level of responsiveness, flexibility, attention to detail, and passion for bringing its clients’ products to market with speed and cost-effectiveness.
For more information, please contact:
# # #